{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:33:31Z","timestamp":1787690011786,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SE 1966\/6-1"],"award-info":[{"award-number":["SE 1966\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KO 4646\/3-1"],"award-info":[{"award-number":["KO 4646\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00774-018-0929-9","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T09:47:01Z","timestamp":1526896021000},"page":"243-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"37","author":[{"given":"D. B.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Komrakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pflug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"von Oertzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. A.","family":"Walde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sehmisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"929_CR1","first-page":"14","volume":"2","author":"N Duquet","year":"2014","unstructured":"Duquet N (2014) Osteoporosis: treatment and pharmaceutical care. J Pharm Belg 2:14\u201324","journal-title":"J Pharm Belg"},{"key":"929_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00104-004-0971-0","volume":"76","author":"R Osterkamp","year":"2005","unstructured":"Osterkamp R (2005) Population developments in Germany until 2050. Chirurg 76:10\u201318","journal-title":"Chirurg"},{"key":"929_CR3","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864\u20131873","journal-title":"CMAJ"},{"key":"929_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results. From the Women\u2019s Health Initiative randomized controlled trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"929_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJMoa0807684","volume":"360","author":"RT Chlebowski","year":"2009","unstructured":"Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360:573\u2013587","journal-title":"N Engl J Med"},{"key":"929_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1634\/theoncologist.5-5-388","volume":"5","author":"DB Muchmore","year":"2000","unstructured":"Muchmore DB (2000) Raloxifene: a selective estrogen receptor modulator (SERM) with multiple target system effects. Oncologist 5:388\u2013392","journal-title":"Oncologist"},{"key":"929_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/jama.282.7.637","volume":"282","author":"B Ettinger","year":"1999","unstructured":"Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gl\u00fcer CC (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637\u2013645","journal-title":"JAMA"},{"key":"929_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bone.2010.06.009","volume":"47","author":"JA Kanis","year":"2010","unstructured":"Kanis JA, Johansson H, Oden A, McCloskey EV (2010) A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX. Bone 47:729\u2013735","journal-title":"Bone"},{"key":"929_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4184\/asj.2016.10.4.787","volume":"10","author":"KC An","year":"2016","unstructured":"An KC (2016) Selective estrogen receptor modulators. Asian Spine J. 10:787\u2013791","journal-title":"Asian Spine J."},{"key":"929_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/8756-3282(95)00441-6","volume":"18","author":"FH Anderson","year":"1996","unstructured":"Anderson FH, Francis RM, Faulkner K (1996) Androgen supplementation in eugonadal men with osteoporosis-effects of 6\u00a0months of treatment on bone mineral density and cardiovascular risk factors. Bone 18:171\u2013177","journal-title":"Bone"},{"key":"929_CR11","first-page":"E853","volume":"267","author":"JH Tobias","year":"1994","unstructured":"Tobias JH, Gallagher A, Chambers TJ (1994) 5 alpha-dihydrotestosterone partially restores cancellous bone volume in osteopenic ovariectomized rats. Am J Physiol 267:E853\u2013E859","journal-title":"Am J Physiol"},{"key":"929_CR12","first-page":"4358","volume":"81","author":"L Katznelson","year":"1996","unstructured":"Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A (1996) Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81:4358\u20134365","journal-title":"J Clin Endocrinol Metab"},{"key":"929_CR13","first-page":"E328","volume":"274","author":"CK Lea","year":"1998","unstructured":"Lea CK, Flanagan AM (1998) Physiological plasma levels of androgens reduce bone loss in the ovariectomized rat. Am J Physiol 274:E328\u2013E335","journal-title":"Am J Physiol"},{"key":"929_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1210\/jc.2003-031110","volume":"89","author":"JK Amory","year":"2004","unstructured":"Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL (2004) Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89:503\u2013510","journal-title":"J Clin Endocrinol Metab"},{"key":"929_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/07435800.2012.668254","volume":"37","author":"M Otto-Duessel","year":"2012","unstructured":"Otto-Duessel M, He M, Jones JO (2012) Tissue-selective regulation of androgen-responsive genes. Endocr Res 37:203\u2013215","journal-title":"Endocr Res"},{"key":"929_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","volume":"14","author":"AS Dobs","year":"2013","unstructured":"Dobs AS, Boccia RV, Croot CC, Gabrail NY, Dalton JT, Hancock ML, Johnston MA, Steiner MS (2013) Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol 14:335\u2013345","journal-title":"Lancet Oncol"},{"key":"929_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","volume":"2","author":"JT Dalton","year":"2011","unstructured":"Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS (2011) The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2:153\u2013161","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"929_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11914-014-0204-5","volume":"12","author":"CM Girgis","year":"2014","unstructured":"Girgis CM, Mokbel N, Digirolamo DJ (2014) Therapies for musculoskeletal disease: can we treat two birds with one stone? Curr Osteoporos Rep 12:142\u2013153","journal-title":"Curr Osteoporos Rep"},{"key":"929_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1517\/13543770902994397","volume":"19","author":"X Zhang","year":"2009","unstructured":"Zhang X, Lanter JC, Sui Z (2009) Recent advances in the development of selective androgen receptor modulators. Expert Opin Ther Pat 19:1239\u20131258","journal-title":"Expert Opin Ther Pat"},{"key":"929_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11095-006-9152-9","volume":"24","author":"JD Kearbey","year":"2007","unstructured":"Kearbey JD, Gao W, Narayanan R, Fisher SJ, Wu D, Miller DD, Dalton JT (2007) Selective androgen receptor modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res 24:328\u2013335","journal-title":"Pharm Res"},{"key":"929_CR21","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s11095-009-9962-7","volume":"26","author":"JD Kearbey","year":"2009","unstructured":"Kearbey JD, Gao W, Fisher SJ, Wu D, Miller DD, Dalton JT (2009) Effects of selective androgen receptor modulator (SARM) treatment in osteopenic female rats. Pharm Res 26:2471\u20132477","journal-title":"Pharm Res"},{"key":"929_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1359\/jbmr.081007","volume":"24","author":"EG Vajda","year":"2009","unstructured":"Vajda EG, Hogue A, Griffiths KN, Chang WY, Burnett K, Chen Y, Marschke K, Mais DE, Pedram B, Shen Y, van Oeveren A (2009) Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats. J Bone Miner Res 24:231\u2013240","journal-title":"J Bone Miner Res"},{"key":"929_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","volume":"15","author":"DN Kalu","year":"1991","unstructured":"Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175\u2013191","journal-title":"Bone Miner"},{"key":"929_CR24","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1097\/BRS.0b013e3181afe846","volume":"34","author":"S Sehmisch","year":"2009","unstructured":"Sehmisch S, Erren M, Rack T, Tezval M, Seidlova-Wuttke D, Richter J, Wuttke W, Stuermer KM, Stuermer EK (2009) Short-term effects of parathyroid hormone on rat lumbar vertebrae. Spine (Phila Pa 1976) 34:2014\u20132021","journal-title":"Spine (Phila Pa 1976)"},{"key":"929_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00198-009-0941-y","volume":"21","author":"M Tezval","year":"2010","unstructured":"Tezval M, Stuermer EK, Sehmisch S, Rack T, Stary A, Stebener M, Konietschke F, Stuermer KM (2010) Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: a new mechanical test for trochanteric region of rat femur. Osteoporos Int 21:251\u2013261","journal-title":"Osteoporos Int"},{"key":"929_CR26","doi-asserted-by":"publisher","first-page":"S168","DOI":"10.1002\/ptr.3060","volume":"24","author":"S Sehmisch","year":"2010","unstructured":"Sehmisch S, Erren M, Kolios L, Tezval M, Seidlova-Wuttke D, Wuttke W, Stuermer KM, Stuermer EK (2010) Effects of isoflavones equol and genistein on bone quality in a rat osteopenia model. Phytother Res 24:S168\u2013S174","journal-title":"Phytother Res"},{"key":"929_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2\u201317","journal-title":"J Bone Miner Res"},{"key":"929_CR28","unstructured":"CEN (2002) European committee for standardization. Determination of calcium and magnesium. EN ISO 7980"},{"key":"929_CR29","unstructured":"CEN (2004) European committee for standardization. Determination of orthophosphate. EN ISO 6878"},{"key":"929_CR30","doi-asserted-by":"publisher","first-page":"6893137","DOI":"10.1155\/2016\/6893137","volume":"2016","author":"DB Hoffmann","year":"2016","unstructured":"Hoffmann DB, Griesel MH, Brockhusen B, Tezval M, Komrakova M, Menger B, Wassmann M, Stuermer KM, Sehmisch S (2016) Effects of 8-prenylnaringenin and whole-body vibration therapy on a rat model of osteopenia. J Nutr Metab 2016:6893137","journal-title":"J Nutr Metab"},{"key":"929_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00223-016-0156-0","volume":"99","author":"M Komrakova","year":"2016","unstructured":"Komrakova M, Hoffmann DB, Nuehnen V, Stueber H, Wassmann M, Wicke M, Tezval M, Stuermer KM, Sehmisch S (2016) The effect of vibration treatments combined with teriparatide or strontium ranelate on bone healing and muscle in ovariectomized rats. Calcif Tissue Int 99:408\u2013422","journal-title":"Calcif Tissue Int"},{"key":"929_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00774-014-0578-6","volume":"33","author":"M Tezval","year":"2014","unstructured":"Tezval M, Hansen S, Schmelz U, Komrakova M, Stuermer KM, Sehmisch S (2014) Effect of urocortin on strength and microarchitecture of osteopenic rat femur. J Bone Miner Metab 33:154\u2013160","journal-title":"J Bone Miner Metab"},{"key":"929_CR33","first-page":"213234","volume":"2013","author":"H Chen","year":"2013","unstructured":"Chen H, Zhou X, Fujita H, Onozuka M, Kubo KY (2013) Age-related changes in trabecular and cortical bone microstructure. Int J Endocrinol 2013:213234","journal-title":"Int J Endocrinol"},{"key":"929_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1359\/jbmr.1997.12.1.89","volume":"12","author":"H Ritzel","year":"1997","unstructured":"Ritzel H, Amling M, Posl M, Hahn M, Delling G (1997) The thickness of human vertebral cortical bone and its changes in aging and osteoporosis: a histomorphometric analysis of the complete spinal column from thirty-seven autopsy specimens. J Bone Miner Res 12:89\u201395","journal-title":"J Bone Miner Res"},{"key":"929_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/BF00439050","volume":"115","author":"M Amling","year":"1996","unstructured":"Amling M, Posl M, Ritzel H, Hahn M, Vogel M, Wening VJ, Delling G (1996) Architecture and distribution of cancellous bone yield vertebral fracture clues. A histomorphometric analysis of the complete spinal column from 40 autopsy specimens. Arch Orthop Trauma Surg 115:262\u2013269","journal-title":"Arch Orthop Trauma Surg"},{"key":"929_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3349\/ymj.2003.44.3.508","volume":"44","author":"V Kavuncu","year":"2003","unstructured":"Kavuncu V, Sahin S, Baydas G, Ilhan N, Ozercan I, Yasar A, Pekkutucu I, Ilhan N, Ozercan R (2003) A comparison of estrogen and two different doses of calcitonin in ovariectomized rats. Yonsei Med J 44:508\u2013516","journal-title":"Yonsei Med J"},{"key":"929_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7:27\u201331","journal-title":"J Basic Clin Pharm"},{"key":"929_CR38","unstructured":"USFDA (2005) Guidance for industry: estimating the maximum safe starting dose in adult healthy volunteer. US Food and Drug Administration"},{"key":"929_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1124\/jpet.110.168880","volume":"334","author":"A Jones","year":"2010","unstructured":"Jones A, Hwang DJ, Duke CB 3rd, He Y, Siddam A, Miller DD, Dalton JT (2010) Nonsteroidal selective androgen receptor modulators enhance female sexual motivation. J Pharmacol Exp Ther 334:439\u2013448","journal-title":"J Pharmacol Exp Ther"},{"key":"929_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1248\/bpb.b12-00885","volume":"36","author":"K Furuya","year":"2013","unstructured":"Furuya K, Yamamoto N, Ohyabu Y, Morikyu T, Ishige H, Albers M, Endo Y (2013) Mechanism of the tissue-specific action of the selective androgen receptor modulator S-101479. Biol Pharm Bull 36:442\u2013451","journal-title":"Biol Pharm Bull"},{"key":"929_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/cmdc.201300348","volume":"9","author":"N Nagata","year":"2014","unstructured":"Nagata N, Furuya K, Oguro N, Nishiyama D, Kawai K, Yamamoto N, Ohyabu Y, Satsukawa M, Miyakawa M (2014) Lead evaluation of tetrahydroquinolines as nonsteroidal selective androgen receptor modulators for the treatment of osteoporosis. ChemMedChem 9:197\u2013206","journal-title":"ChemMedChem"},{"key":"929_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrneph.2014.49","volume":"10","author":"JJ Scialla","year":"2014","unstructured":"Scialla JJ, Wolf M (2014) Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol 10:268\u2013278","journal-title":"Nat Rev Nephrol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0929-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-018-0929-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-018-0929-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T15:46:42Z","timestamp":1568908002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-018-0929-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1007\/s00774-018-0929-9","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"2 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}